Prostatic Hypertrophy

DBCOND0079911Urogenital Diseases

Prostatic Hypertrophy is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0489821ICD-10N40SNOMED CT197958000MedDRA10004446UMLSC1704272

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
12Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Prostatic Hypertrophy share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In